The association of bacteriuria and reduced serum pyridoxal concentrations in patients with diabetes mellitus. 1981

R E Davis, and V J McCann, and N W Ormonde, and C S Goodwin

Of 1017 patients admitted to the Royal Perth Hospital Diabetic Survey 142 were found to have significant bacteriuria. In these bacteriuric patients serum pyridoxal concentrations were significantly reduced (P = less than 0.001) when compared with 142 diabetic patients matched for age (+/- 5 years) and sex but without infection of the urinary tract. Measurements were repeated up to 6 mth after antibacterial treatment and serum pyridoxal concentrations were still low. Pyridoxal has a role in immunological competence, and it is possible that the increased incidence of urinary tract infection in patients with diabetes reflects impaired immunological competence due to pyridoxal deficiency.

UI MeSH Term Description Entries
D011730 Pyridoxal The 4-carboxyaldehyde form of VITAMIN B 6 which is converted to PYRIDOXAL PHOSPHATE which is a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid.
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D001437 Bacteriuria The presence of bacteria in the urine which is normally bacteria-free. These bacteria are from the URINARY TRACT and are not contaminants of the surrounding tissues. Bacteriuria can be symptomatic or asymptomatic. Significant bacteriuria is an indicator of urinary tract infection. Bacteriurias
D014552 Urinary Tract Infections Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA. Infection, Urinary Tract,Infections, Urinary Tract,Tract Infection, Urinary,Tract Infections, Urinary,Urinary Tract Infection
D048909 Diabetes Complications Conditions or pathological processes associated with the disease of diabetes mellitus. Due to the impaired control of BLOOD GLUCOSE level in diabetic patients, pathological processes develop in numerous tissues and organs including the EYE, the KIDNEY, the BLOOD VESSELS, and the NERVE TISSUE. Complications of Diabetes Mellitus,Diabetes-Related Complications,Diabetic Complications,Diabetes Complication,Diabetes Mellitus Complication,Diabetes Mellitus Complications,Diabetes Related Complications,Diabetes-Related Complication,Diabetic Complication

Related Publications

R E Davis, and V J McCann, and N W Ormonde, and C S Goodwin
April 1977, Pathology,
R E Davis, and V J McCann, and N W Ormonde, and C S Goodwin
January 1981, Revista cubana de medicina tropical,
R E Davis, and V J McCann, and N W Ormonde, and C S Goodwin
August 1965, Ugeskrift for laeger,
R E Davis, and V J McCann, and N W Ormonde, and C S Goodwin
April 1990, Mikrobiyoloji bulteni,
R E Davis, and V J McCann, and N W Ormonde, and C S Goodwin
January 1991, Reviews of infectious diseases,
R E Davis, and V J McCann, and N W Ormonde, and C S Goodwin
February 2002, European journal of clinical investigation,
R E Davis, and V J McCann, and N W Ormonde, and C S Goodwin
December 1991, Clinica chimica acta; international journal of clinical chemistry,
R E Davis, and V J McCann, and N W Ormonde, and C S Goodwin
January 1978, British medical journal,
R E Davis, and V J McCann, and N W Ormonde, and C S Goodwin
January 2002, Journal of diabetes and its complications,
R E Davis, and V J McCann, and N W Ormonde, and C S Goodwin
March 2004, The Annals of pharmacotherapy,
Copied contents to your clipboard!